{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:40:57Z","timestamp":1790206857277,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1364,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1998,4]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To compare beclomethasone dipropionate 3\u2003mg\/60 mL enema (BDP) and prednisolone sodium phosphate 30\u2003mg\/60mL enema (PP) once daily in patients with active distal ulcerative colitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>One hundred and fifty\u2010seven patients were enrolled in a multicentre, 4\u2010week, randomized, double\u2010blind trial. Patients were assessed at baseline, 2 and 4\u2003weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Both treatment groups showed statistically significant improvement of clinical activity after 2 and 4\u2003weeks. Endoscopy and biopsy showed a reduction in the activity score at the end of the treatment period in both groups. No statistically significant difference was observed between the two treatment groups. After 4\u2003weeks, 29% of patients in the BDP group and 25% in the PP group were considered to be in clinical remission; an improvement was observed in 40% of patients on BDP and in 47% on PP. Mean morning plasma cortisol levels showed a slight but significant reduction in the PP group, while the ACTH test showed that neither drug interfered with the hypothalamic\u2013pituitary\u2013adrenal (HPA) axis function. No significant changes were observed in the laboratory tests. Finally, there was a low incidence of adverse events in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>It is concluded that, in the topical treatment of active distal ulcerative colitis, BDP 3\u2003mg enemas are as efficacious as PP 30\u2003mg enemas, without interference with the HPA axis.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1998.00299.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:36:26Z","timestamp":1047353786000},"page":"361-366","source":"Crossref","is-referenced-by-count":49,"title":["Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis"],"prefix":"10.1111","volume":"12","author":[{"family":"Campieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Cottone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Miglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Manenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Astegiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"D\u2019arienzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Manguso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"D\u2019albasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bonanomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Galeazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Gionchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5104.1072"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5171.464"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91528-9"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.3.215"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","unstructured":"MattsSFG KelleherJ WhartonBA et al.Adrenal cortical and pituitary function after intrarectal steroid therapy.Br Med J1963;2: 24\u20136.","DOI":"10.1136\/bmj.2.5348.24"},{"key":"e_1_2_6_7_2","first-page":"98","article-title":"Systemic effects of rectally administered corticosteroid","volume":"28","author":"Reshef R","year":"1992","journal-title":"Isr J Med Sci"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","unstructured":"CannPA&HoldsworthCD.Systemic absorption from hydrocortisone foam enema in ulcerative colitis.Lancet1987; i:9223.","DOI":"10.1016\/S0140-6736(87)92900-X"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.20.5.349"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1155\/1990\/708916"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90051-C"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198428020-00002"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198733050-00001"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.5.1565"},{"key":"e_1_2_6_15_2","first-page":"20","article-title":"Some properties of beclomethasone dipropionate and related steroids in man","volume":"51","author":"Harris DM.","year":"1975","journal-title":"Postgrad Med J"},{"key":"e_1_2_6_16_2","article-title":"Topical beclomethasone dipropionate enemas improve distal ulcerative colitis and idiopathic proctitis without systemic toxicity","volume":"88","author":"Levine DS","year":"1985","journal-title":"Gastroenterology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91747-0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02556177"},{"key":"e_1_2_6_19_2","first-page":"18","article-title":"Comparison of beclomethasone dipropionate (2 and 3\u2003mg) and prednisolone sodium phosphate enemas (30\u2003mg) in the treatment of ulcerative proctitis. An adrenocortical approach","volume":"35","author":"Mulder CJJ","year":"1989","journal-title":"Neth J Med"},{"key":"e_1_2_6_20_2","first-page":"11","article-title":"Metabolism of beclomethasone dipropionate by animals and man","volume":"51","author":"Martin L","year":"1975","journal-title":"Postgrad Med J"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5375.89"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.4979.1315"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5104.1077"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(60)90450-5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199102000-00009"},{"key":"e_1_2_6_26_2","article-title":"Comparison of beclomethasone dipropionate (BDP) and prednisolone 21\u2010phosphate (PP) enemas in distal ulcerative colitis. A double blind study","volume":"88","author":"Tytgat GNJ","year":"1985","journal-title":"Gastroenterology"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198804000-00013"},{"key":"e_1_2_6_28_2","article-title":"A controlled randomized trial of beclomethasone dipropionate (3\u2003mg) vs. 5\u2010aminosalicylic acid (1\u2003g) vs. the combination of both (3\u2003mg\/1\u2003g) as retention enemas in active distal ulcerative colitis","volume":"106","author":"Mulder CJJ","year":"1994","journal-title":"Gastroenterology"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00299.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00299.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1998.00299.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T01:54:08Z","timestamp":1698458048000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1998.00299.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1046\/j.1365-2036.1998.00299.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1998.00299.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}